Friedenthal Financial Buys New Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Friedenthal Financial acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 128 shares of the biotechnology company’s stock, valued at approximately $51,000.

A number of other institutional investors have also recently made changes to their positions in AXON. Avantax Advisory Services Inc. boosted its holdings in Axon Enterprise by 0.8% in the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after acquiring an additional 40 shares in the last quarter. GSA Capital Partners LLP acquired a new position in Axon Enterprise during the 1st quarter valued at approximately $931,000. Zurich Insurance Group Ltd FI raised its holdings in shares of Axon Enterprise by 1.9% in the second quarter. Zurich Insurance Group Ltd FI now owns 205,015 shares of the biotechnology company’s stock worth $60,324,000 after buying an additional 3,832 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of Axon Enterprise by 14.8% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 170,376 shares of the biotechnology company’s stock worth $53,307,000 after buying an additional 22,013 shares during the period. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in shares of Axon Enterprise by 21.7% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 9,153 shares of the biotechnology company’s stock valued at $2,693,000 after buying an additional 1,634 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AXON. JMP Securities lifted their price target on Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Barclays increased their price target on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird raised their target price on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a research report on Tuesday, September 10th. Bank of America began coverage on shares of Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 target price for the company. Finally, Jefferies Financial Group assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $365.38.

Insider Activity

In other news, Director Julie A. Cullivan sold 900 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the sale, the director now owns 3,653 shares in the company, valued at approximately $1,291,445.09. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $437.98, for a total value of $437,980.00. Following the sale, the director now directly owns 26,259 shares in the company, valued at $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Julie A. Cullivan sold 900 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now owns 3,653 shares in the company, valued at approximately $1,291,445.09. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 371,172 shares of company stock valued at $137,000,162 in the last ninety days. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 0.8 %

AXON stock opened at $438.05 on Friday. Axon Enterprise, Inc. has a twelve month low of $199.29 and a twelve month high of $440.89. The stock has a market cap of $33.10 billion, a P/E ratio of 115.58, a PEG ratio of 11.74 and a beta of 0.94. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The company’s 50 day moving average is $388.71 and its two-hundred day moving average is $331.64.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business’s revenue was up 34.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.80 EPS. Research analysts expect that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.